AK
Arthur M Krieg
Chief Scientific Officer

Arthur M Krieg insider trades: Checkmate Pharmaceuticals (CMPI) stock buys and sales

Chief Scientific Officer, Checkmate Pharmaceuticals Last trade Jun 18, 2021 22 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
13
Open-market trades
since 2006
3
Companies
last trade 2021

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Arthur reports to the SEC

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 18, 2021CMPI↑ Buy$44K
Jun 16, 2021CMPI↑ Buy$22K
May 18, 2021CMPI↑ Buy$174K
Mar 29, 2021CMPI↑ Buy10b5-1$371K
Mar 26, 2021CMPI↑ Buy10b5-1$166K
Jan 27, 2021CMPI↑ Buy$22K
Jan 19, 2021CMPI↑ Buy$7K
Dec 29, 2020CMPI↑ Buy$6K
Dec 22, 2020CMPI↑ Buy$75K
Dec 16, 2020CMPI↑ Buy$71K
Aug 29, 2007COLY↓ Sell$40K
Dec 7, 2006COLY↓ Sell$41K
Oct 13, 2006COLY↓ Sell$25K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Arthur M Krieg's insider trades

Arthur M Krieg is Chief Scientific Officer at Checkmate Pharmaceuticals (CMPI). Since Oct 13, 2006, Arthur has reported 10 open-market purchases worth $958K and 3 sales worth $105K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (4 filings), other transactions (2 filings), gifts (1 filing), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CMPI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.